LOPROX 1 %
CICLOPIROX OLAMINE : 1 % · DIN 02221810 · BAUSCH HEALTH, CANADA INC.
Health Canada status: MARKETED
What is LOPROX?
LOPROX 1 % contains CICLOPIROX OLAMINE : 1 %. It is listed in the Health Canada Drug Product Database under DIN 02221810, held by BAUSCH HEALTH, CANADA INC., supplied as LOTION for TOPICAL administration. Health Canada currently lists it as marketed, status dated 27-Nov-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is LOPROX used for?
LOPROX is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, Microsporum canis; cutaneous candidiasis (moniliasis) due to Candida albicans; and tinea (pityriasis) versicolor due to Malassezia furfur.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is LOPROX called?
The same molecule, CICLOPIROX, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| MICOLAMINA | Latin | Brazil |
| CICLOPIROX OLAMINA | Latin | Brazil |
| LAKESIAMEDICAL | Latin | Brazil |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02221810 |
|---|---|
| Brand name | LOPROX |
| Generic / active ingredient | CICLOPIROX OLAMINE : 1 % |
| Manufacturer | BAUSCH HEALTH, CANADA INC. |
| Strength | 1 % |
| Dosage form | LOTION |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D01AE14 CICLOPIROX |
| AHFS class | 84:04.08.20 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 27-Nov-2020 |
| Original market date | 1997-03-24 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02221810 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2221810 |
| Brand name | LOPROX |
| Active ingredient / INN | CICLOPIROX OLAMINE : 1 % |
| ATC code | D01AE14 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D01 |
| AHFS class | 84:04.08.20 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | BAUSCH HEALTH, CANADA INC. |
How is it stored and handled?
Store at room temperature, i.e. 15 - 30 °C.
How is it supplied?
Cream is available in tubes of 60 g. Lotion is available in a 60 mL bottle. Cream samples available in tubes of 2 g.
Which pack is which?
| Strength on the label | 1 % |
|---|---|
| Dosage form | LOTION |
| Route | TOPICAL |
| Packaging as described in the monograph | Cream is available in tubes of 60 g. Lotion is available in a 60 mL bottle. Cream samples available in tubes of 2 g. |
| Storage | Store at room temperature, i.e. 15 - 30 °C. |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
What can be used instead?
Other Canadian products sharing ATC code D01AE14 CICLOPIROX. 4 of 12 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-CICLOPIROX | 8 % | SOLUTION | APOTEX INC | MARKETED | DIN 02298953 |
| LOPROX | 1 % | CREAM | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02221802 |
| TARO-CICLOPIROX | 8 % | SOLUTION | TARO PHARMACEUTICALS INC | MARKETED | DIN 02353288 |
| CICLOPIROX TOPICAL SOLUTION | 8 % | SOLUTION | STERIMAX INC | CANCELLED POST MARKET | DIN 02410346 |
| LOPROX CREAM 1% | 10 MG | CREAM | HOECHST ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 01987569 |
| LOPROX CRM 1% | 10 MG | CREAM | HOECHST CANADA INC. | CANCELLED POST MARKET | DIN 00593362 |
| LOPROX LOTION 1.0% | 1 % | LOTION | HOECHST ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 01989626 |
| LOPROX LOTION 1% | 10 MG | LOTION | HOECHST CANADA INC. | CANCELLED POST MARKET | DIN 00836281 |
| PENLAC | 8 % | SOLUTION | BAUSCH HEALTH, CANADA INC. | DORMANT | DIN 02250535 |
| PMS-CICLOPIROX | 8 % | SOLUTION | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02413574 |
Who else supplies CICLOPIROX worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CICLOPIROX appears in 684 registered pack listings across 8 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does CICLOPIROX cost around the world?
CICLOPIROX is listed on 4 national price registers Nexara tracks, across 44 pack listings published on 4 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 5 | 27 | 03 Sep 2026 |
| Spain | PVP con IVA (public price) | 10 | 10 | 05 Sep 2026 |
| Brazil | preco fabrica (ex-factory ceiling) | 3 | 4 | 02 Sep 2026 |
| Greece | producer price (ex-factory) | 3 | 3 | 03 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.